Logo image of EXAI.MI

EXPERT.AI SPA (EXAI.MI) Stock Fundamental Analysis

BIT:EXAI - Euronext Milan - IT0004496029 - Common Stock - Currency: EUR

1.108  0 (-0.36%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EXAI. EXAI was compared to 101 industry peers in the Software industry. EXAI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EXAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EXAI has reported negative net income.
In the past year EXAI had a positive cash flow from operations.
EXAI had negative earnings in each of the past 5 years.
In multiple years EXAI reported negative operating cash flow during the last 5 years.
EXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFEXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

With a Return On Assets value of -41.16%, EXAI is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
EXAI has a Return On Equity of -277.75%. This is amonst the worse of the industry: EXAI underperforms 82.83% of its industry peers.
Industry RankSector Rank
ROA -41.16%
ROE -277.75%
ROIC N/A
ROA(3y)-13.58%
ROA(5y)-9.5%
ROE(3y)-25.01%
ROE(5y)-18.26%
ROIC(3y)N/A
ROIC(5y)N/A
EXAI.MI Yearly ROA, ROE, ROICEXAI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -10 -20 -30 -40

1.3 Margins

EXAI has a better Gross Margin (86.10%) than 82.83% of its industry peers.
EXAI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for EXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y0.73%
EXAI.MI Yearly Profit, Operating, Gross MarginsEXAI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

1

2. Health

2.1 Basic Checks

EXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXAI has been increased compared to 1 year ago.
The number of shares outstanding for EXAI has been increased compared to 5 years ago.
Compared to 1 year ago, EXAI has a worse debt to assets ratio.
EXAI.MI Yearly Shares OutstandingEXAI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
EXAI.MI Yearly Total Debt VS Total AssetsEXAI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

EXAI has an Altman-Z score of 1.91. This is not the best score and indicates that EXAI is in the grey zone with still only limited risk for bankruptcy at the moment.
EXAI has a Altman-Z score (1.91) which is comparable to the rest of the industry.
The Debt to FCF ratio of EXAI is 30.16, which is on the high side as it means it would take EXAI, 30.16 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 30.16, EXAI perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
EXAI has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
EXAI's Debt to Equity ratio of 1.59 is on the low side compared to the rest of the industry. EXAI is outperformed by 79.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 30.16
Altman-Z 1.91
ROIC/WACCN/A
WACC8.56%
EXAI.MI Yearly LT Debt VS Equity VS FCFEXAI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

EXAI has a Current Ratio of 0.94. This is a bad value and indicates that EXAI is not financially healthy enough and could expect problems in meeting its short term obligations.
EXAI has a worse Current ratio (0.94) than 70.71% of its industry peers.
A Quick Ratio of 0.94 indicates that EXAI may have some problems paying its short term obligations.
The Quick ratio of EXAI (0.94) is worse than 67.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
EXAI.MI Yearly Current Assets VS Current LiabilitesEXAI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

4

3. Growth

3.1 Past

EXAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -105.53%.
EXAI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.44%.
EXAI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.37% yearly.
EPS 1Y (TTM)-105.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.2%
Revenue 1Y (TTM)6.44%
Revenue growth 3Y-8.14%
Revenue growth 5Y-5.37%
Sales Q2Q%-10.19%

3.2 Future

EXAI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.19% yearly.
Based on estimates for the next years, EXAI will show a quite strong growth in Revenue. The Revenue will grow by 9.50% on average per year.
EPS Next Y70.99%
EPS Next 2Y48.91%
EPS Next 3Y33.19%
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2Y7.82%
Revenue Next 3Y9.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXAI.MI Yearly Revenue VS EstimatesEXAI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
EXAI.MI Yearly EPS VS EstimatesEXAI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXAI. In the last year negative earnings were reported.
EXAI is valuated quite expensively with a Price/Forward Earnings ratio of 36.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXAI is on the same level as its industry peers.
EXAI is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 36.21
EXAI.MI Price Earnings VS Forward Price EarningsEXAI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

62.63% of the companies in the same industry are more expensive than EXAI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXAI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 170.28
EV/EBITDA 19.69
EXAI.MI Per share dataEXAI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 -0.3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXAI's earnings are expected to grow with 33.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.91%
EPS Next 3Y33.19%

0

5. Dividend

5.1 Amount

EXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXPERT.AI SPA

BIT:EXAI (3/7/2025, 7:00:00 PM)

1.108

0 (-0.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-27 2024-09-27
Earnings (Next)03-28 2025-03-28/amc
Inst Owners3.6%
Inst Owner ChangeN/A
Ins Owners10.04%
Ins Owner ChangeN/A
Market Cap107.85M
Analysts42.22
Price Target1.53 (38.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.21
P/S 5.24
P/FCF 170.28
P/OCF 18.83
P/B 13.52
P/tB N/A
EV/EBITDA 19.69
EPS(TTM)-0.33
EYN/A
EPS(NY)0.03
Fwd EY2.76%
FCF(TTM)0.01
FCFY0.59%
OCF(TTM)0.06
OCFY5.31%
SpS0.21
BVpS0.08
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.16%
ROE -277.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.1%
FCFM 3.08%
ROA(3y)-13.58%
ROA(5y)-9.5%
ROE(3y)-25.01%
ROE(5y)-18.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y0.73%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 30.16
Debt/EBITDA 2
Cap/Depr 73.04%
Cap/Sales 24.78%
Interest Coverage N/A
Cash Conversion 90.07%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 1.91
F-Score4
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)132.99%
Cap/Depr(5y)117.3%
Cap/Sales(3y)39.81%
Cap/Sales(5y)33.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.2%
EPS Next Y70.99%
EPS Next 2Y48.91%
EPS Next 3Y33.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.44%
Revenue growth 3Y-8.14%
Revenue growth 5Y-5.37%
Sales Q2Q%-10.19%
Revenue Next Year5.52%
Revenue Next 2Y7.82%
Revenue Next 3Y9.5%
Revenue Next 5YN/A
EBIT growth 1Y57.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year189.77%
EBIT Next 3Y50.67%
EBIT Next 5YN/A
FCF growth 1Y-82.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.99%
OCF growth 3YN/A
OCF growth 5YN/A